Pfizer finally makes decision on whether or not it will split into two companies
Pfizer to buy Medivation in $14 billion deal
Prescription drug prices rising at a record rate in America
Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel
Pfizer, Allergan scrap $160B deal after US tax rule change
Bloomberg: Ted Cruz 'says some of the stupidest things I've ever heard'
Market Wrap: Wall Street Falls; Pfizer, Allergan Drag
Democratic candidate Sanders condemns Pfizer-Allergan deal as 'disaster'
Pfizer to buy Allergan in $160 billion deal
Pfizer set to buy Allergan for more than $150B
Market Wrap: S&P 500 Scores Best Week in Nearly a Year
Can Hipsters and the Artisan Economy Save the Middle Class?
After Market: New Records Again for Dow, S&P 500
Buyout Blunders: 5 Firms That Should've Said Yes to the Deals
Money Minute: Pink Slime Is Back; Pfizer's AstraZeneca Bid Is Gone
After Market: Tech Giants Make Peace; AT&T Makes a Deal
The Truth About Corporate America's Biggest Tax Dodgers
After Market: A Mixed Bag of Economic Reports Lifts Stocks
After Market: China Contraction Fears Can't Hold Stocks Down
Pfizer Sales Way Off Mark as Drugmaker Pursues AstraZeneca
After Market: Ukraine Strikes Back, Investors Duck for Cover
After Market: A Volatile Roller Coaster Ride on Wall Street
After Market: Modest Gains Stretch S&P 500 Winning Streak
Money Minute: Pfizer Seeks Merger with Reluctant AstraZeneca
After Market: Internet High-Flyers Continue Their 3-Day Dive
Dogs of the Dow: Mangy Mutts or an Investor's Best Friends?
After Market: High Techs and Biotechs Drag Indexes Down
After Market: Upbeat Economic News and Calm in Crimea Propel Stocks Higher
After Market: A Mixed Day Overall, but a Great Day for 2 Biotechs
After Market: Good News on the Economy Couldn't Generate a Bounce